News & Events 2008
01 October 2008
The Head Office of Incepta was shifted to its newly purpose built building located in Tejgaon, Dhaka. Incepta started its Head Office operation from a rented space in Shantinagar, Dhaka on 1st of August 1999. With the growth of the company it became necessary to have bigger space for smooth operation. Incepta group bought a piece of land in the center of Dhaka city at Tejgaon. By September 2007, the office space was ready for operation. Apart from the Head Office, this multipurpose building also houses the Dhaka Sales office, Central Warehouse and Dhaka Depot operations.
19 March 2008
Accreditation with European GMP (Good Manufacturing Practice) certification to Incepta Pharmaceuticals Ltd. will create a new era in exporting pharmaceutical products. - Dr. A M M Shawkat Ali.
The achievements of Pharmaceutical industry in last few years are undoubtedly praise worthy. On this succession accreditation with European GMP (Good Manufacturing Practice) certification by Incepta Pharmaceuticals Ltd. will create a new era in exporting pharmaceutical products. Dr. A M M Shawkat Ali, Honorable advisor, Ministry of Health and Family Welfare and Ministry of Food and Disaster Management, addressed this on a program organized by Incepta Pharmaceuticals Ltd. on 14th March at Hotel Sonargaon on the occasion of receiving European GMP (Good Manufacturing Practice) certification. The pharmaceutical industry has created tremendous potentiality to earn foreign currency, he added. He assured all the possible assistances from the Government to add muscle in this particular sector.
The program started with the welcome speech of Mr. Abdul Muktadir, Managing Director of Incepta Pharmaceuticals Ltd. Besides Mr. Charles Whitley, Charge D Affairs of European Commission, Brig. Gen. Sarker M A Matin, Director, Directorate of Drug Administration, Mr. S M Shafiuzzaman, President, Bangladesh Association of Pharmaceuticals Industries, Austrian pharmaceutical marketing specialist Mr. Joerg Kloppert also delivered their speech.
According to Mr. Abdul Muktadir, Incepta has earned remarkable goodwill both home and abroad in manufacturing high quality medicine. On this succession the achievement of this GMP certificate from European Commission has created new possibilities. The respect and position of local pharmaceutical industry will enhance to a great extent internationally by this achievement and the scope of exporting will be higher than ever before. Entrepreneurs and top management of many Pharma companies, renowned physicians, reputed pharmacists, representatives of foreign embassies, and civil society were also present in the evening.
To mention, by exporting in 19 countries, Incepta is not only bringing fame for the country, but also contributing remarkably in the development of national economy by earning foreign remittance. Incepta Pharmaceuticals Ltd. received accreditation with the European GMP certification on 11th January this year which will allow the company to export in all the countries of European Union and this certification is first ever for any local company.
The achievements of Pharmaceutical industry in last few years are undoubtedly praise worthy. On this succession accreditation with European GMP (Good Manufacturing Practice) certification by Incepta Pharmaceuticals Ltd. will create a new era in exporting pharmaceutical products. Dr. A M M Shawkat Ali, Honorable advisor, Ministry of Health and Family Welfare and Ministry of Food and Disaster Management, addressed this on a program organized by Incepta Pharmaceuticals Ltd. on 14th March at Hotel Sonargaon on the occasion of receiving European GMP (Good Manufacturing Practice) certification. The pharmaceutical industry has created tremendous potentiality to earn foreign currency, he added. He assured all the possible assistances from the Government to add muscle in this particular sector.
The program started with the welcome speech of Mr. Abdul Muktadir, Managing Director of Incepta Pharmaceuticals Ltd. Besides Mr. Charles Whitley, Charge D Affairs of European Commission, Brig. Gen. Sarker M A Matin, Director, Directorate of Drug Administration, Mr. S M Shafiuzzaman, President, Bangladesh Association of Pharmaceuticals Industries, Austrian pharmaceutical marketing specialist Mr. Joerg Kloppert also delivered their speech.
According to Mr. Abdul Muktadir, Incepta has earned remarkable goodwill both home and abroad in manufacturing high quality medicine. On this succession the achievement of this GMP certificate from European Commission has created new possibilities. The respect and position of local pharmaceutical industry will enhance to a great extent internationally by this achievement and the scope of exporting will be higher than ever before. Entrepreneurs and top management of many Pharma companies, renowned physicians, reputed pharmacists, representatives of foreign embassies, and civil society were also present in the evening.
To mention, by exporting in 19 countries, Incepta is not only bringing fame for the country, but also contributing remarkably in the development of national economy by earning foreign remittance. Incepta Pharmaceuticals Ltd. received accreditation with the European GMP certification on 11th January this year which will allow the company to export in all the countries of European Union and this certification is first ever for any local company.
21 January 2008
The Pharmacy and Poisons Board, Ministry of Health of the Republic of Kenya issued GMP certificates to Incepta Pharmaceuticals Ltd. for cephalosporin, solid and liquid products.
